Presentation is loading. Please wait.

Presentation is loading. Please wait.

Good Morning~ Welcome! Today’s presentation is sponsored by the Florida Department of Transportation Our host agency is the Central Florida Regional Planning.

Similar presentations


Presentation on theme: "Good Morning~ Welcome! Today’s presentation is sponsored by the Florida Department of Transportation Our host agency is the Central Florida Regional Planning."— Presentation transcript:

1 Good Morning~ Welcome! Today’s presentation is sponsored by the Florida Department of Transportation Our host agency is the Central Florida Regional Planning Council Presenter is: Diana Byrnes Substance Abuse Management Specialist; C-SAPA Center for Urban Transportation Research University of South Florida, Tampa Campus

2 Video Clean Sober and Safe,
Produced by the Center for Urban Transportation Research This portion of the video explains the background of DOT required drug testing Available for download from

3 DOT Required Drug and Alcohol Testing Program Management

4 Regulations US DOT Regulations: 49 CFR Part 40
FTA: 49 CFR Part 655 (OR) FMCSA: 49 CFR Part 382 Employer Policy

5 All DOT Modes are subject to 49 CFR Part 40
Department of Transportation FTA PHMSA FAA FMCSA FRA All DOT Modes are subject to 49 CFR Part 40

6 49 CFR Part 40 US DOT Regulations
All DOT modes must comply with Part 40 This regulation tells us how to conduct drug and alcohol testing Explains procedures for collection of specimens; testing for alcohol; analysis of specimen; MRO verification process; reporting of results; and the return to duty (SAP) process Part 40 also includes provision for drug and alcohol background checks (40.25)

7 Parties Subject to Part 40
DOT Employer SAP Collector MRO Laboratory

8 Employer Responsibilities

9 Substance Abuse Policy
Each mode has specific policy provisions, but in all cases your policy must identify which components are conducted under agency authority and which are conducted under DOT authority Okay to reference the regulations, as long as employees are provided access to the regulations referenced Policy must be adopted by a governing board or agency official (in order for it to be legally defensible) Policy must be disseminated to all covered employees prior to the performance of safety sensitive duties and each time there are major revisions made to the policy Enforcement of policy must be consistent

10 Employee and Supervisor Training
FTA requires that all covered employees receive a min. of 60 minutes of drug awareness training (Clean, Sober and Safe will satisfy only 23 minutes) If alcohol awareness training is provided, must be in addition to the 60 min. minimum FMCSA requires that employers distribute information material to all covered drivers Policy should be reviewed as one of the pieces of informational material

11 Testing Program

12 Test Types Pre-employment Random Post Accident Reasonable Suspicion
Return to Duty Follow Up

13 Pre-employment Testing
Negative result required before performance of safety sensitive functions (FMCSA allows for transfer from one employer to another without pre-employment test, as long as employee has been in testing program for one year without violation) Urine drug test is required; alcohol test is permitted for this test type Extended absence and removal from the random testing pool requires a pre-employment test upon return to work (30 days for FMCSA and 90 for FTA)

14 Pre-employment D& A Background Checks
40.25 FTA requirement is DOT employers two years back FMCSA extends to DOT employers three years back Must get employee consent; if employee fails to give consent– they may not perform safety sensitive duties If you do not receive reply, employee can remain working– but you must be able to show that you have made attempts to obtain the information If you receive notice that employee has violated the program; you need to ensure that SAP and RTD process has been successfully completed. You are also responsible for continuing any follow up testing requirements.

15 Random Testing Each DOT mode sets the testing rates for this test type (FTA: 25/10; FMCSA: 50/10) Random testing must be spread reasonably throughout all days of the week and all hours that safety sensitive functions are performed* FTA requirement Random testing schedules should never reveal a predictable pattern of testing i.e.: NO group testing Employee must report immediately to collection facility– no advance notice should be given

16 Post Accident Each DOT mode defines the criteria for an accident or incident to be subject to post accident testing When criteria is met; both drug and alcohol testing must be conducted- use of decision and documentation form is highly recommended Testing windows are the same for both FMCSA and FTA: alcohol up to 8 hours, drug up to 32 hours begin documenting delays after first two hours

17 Reasonable Suspicion Most underutilized test type despite training requirements Supervisors must be trained in signs and symptoms of probable drug use and probable alcohol misuse FMCSA: Documentation is required within 24 hours of observed behavior or before drug test results report FTA: No documentation is required; but it is highly suggested. If audited, it will be expected Best Practice: Keep supervisor training documentation on file indefinitely

18 Return to Duty and Follow Up Test Types
Only applicable when an employee has violated the DOT rule Violation means: Employee tested positive or refused to test when required A negative RTD is required before returning to safety sensitive functions after a rule violation (After extended absences use pre-employment test type not return to duty!) Follow up testing plan is determined by SAP with a min. of 6 tests in 12 months Employees are still subject to all other test types during follow up testing plan Employer option to conduct these tests under direct observation (highly recommended)

19 Urine Collections

20 Urine Specimen Collections
Collector must meet Part 40 qualifications Collection site must meet Part 40 qualifications A Federal custody and control form must be used for all DOT required tests A split specimen method must be used for all DOT required tests Collector must send specimen to a DHHS certified lab for analysis (cannot use instant test method or any other method of analysis)

21 Basic Collection Procedures
Collector checks identification and explains process to donor. Collector begins filling in the CCF Collector instructs donor to empty pockets, remove outer garments, etc. Collector instructs donor to wash hands Collector secures stall (checking for any possible contaminates or water sources) Collector instructs donor to fill collection cup to at least 45 mL

22 Basic Collection Procedures Cont.
Collector checks specimen for temperature and looks for signs of adulteration or substitution (odor, color, odd appearance) Collector splits sample into A and B bottle Collector asks donor to sign Step 5 and initial seals after seals are affixed to bottles.*** Collector completes paperwork and packages the lab copy of CCF with the specimen bottles in bag (in the donor’s view) Donor is given the employee copy of CCF and is then permitted to leave testing site Collector then disseminates the MRO and Employer copies of the CCF

23 Collection Irregularities
Shy bladder If donor is unable to supply a 45 ml of urine on the first attempt: The void is discarded (unless out of temp. range or otherwise appears to have been tampered with) Donor is urged to consume up to 40 ounces of fluid and is given up to 3 hours to provide 45 ml of urine in one single void. Attempts and fluid consumed are recorded on CCF by collector After 3 hours; donor is released to employer but must be examined by a physician within 5 days to determine if legitimate medical excuse No medical explanation; deemed as refusal. Failure to comply with requirement; deemed as refusal

24 Collection Irregularities Cont.
Specimen Temperature out of range Specimen falls outside of the degree range Not humanly possible, donor is attempting to substitute or adulterate the specimen Collector must initiate an immediate recollection under direct observation First specimen is NOT discarded, it is sent to the lab, with comments in remarks section indicating that it is 1 of 2 specimens for the same donor (specimen ID numbers should be referenced) Common error: Collector fails to initiate the DO collection and follows shy bladder instructions instead

25 Collection Irregularities Cont.
Donor fails to cooperate with any part of the testing process, for example: Does not report immediately to testing site in time allotted by employer Refuses to empty pockets Refuses to wash hands Leaves the site before process is complete Is caught with items intended to tamper with or substitute their specimen

26 How are Directly Observed Collections Conducted?
Recently enhanced; effective August 25, 2008. ALL Directly Observed Collections must occur in this manner: Collector/Observer must be same gender as donor If collector is not same gender, DER or other company official may be asked to serve as “observer” Donor must raise clothing above the waist and lower clothing (including under garments) to mid thigh Donor must turn completely around to reveal to the observer that no prosthetic device is being used Observer must watch the donor’s urine leave the body and enter the collection cup (this part has not changed)

27 Directly Observed Collection Enhancements- Why?
Directly observed collections are only conducted when there is reason to believe that an employee or applicant is attempting to thwart the drug testing process The enhancements to the directly observed collection procedures are intended to deter employees from attempting to use prosthetic devices

28 Who can order a Directly Observed Collection?
As an employer, you can order a directly observed collection when your policy specifies that return to duty and follow up testing will be conducted in this manner and when a test was cancelled due to a fatal flaw and a negative result is required A collector can initiate direct observation collection procedures when a donor exhibits behavior that could be considered an attempt to conceal an adulterant, a substituted sample or a prosthetic device An MRO can initiate recollection under direct observation when there are irregularities with the specimen- MRO will instruct employer when this is required

29 Employer Best Practices For Collection Procedures
Use a “Testing Notification Form” Determine a reasonable time for employees to report to site– then let collectors know that delays must be reported to you Ensure that all collectors are aware of how to reach you (the DAPM/DER) in the event of an irregularity in the collection process Ensure that collection sites are willing and able to conduct directly observed collections in accordance with Part 40 (same gender available?)

30 Alcohol Testing Alcohol use is prohibited within 4 hours of performing safety sensitive duties (both FTA and FMCSA) Saliva screening may be used Confirmation test must always be made with EBT Alcohol testing must take place following any accident that meets the criteria to test An employee with an alcohol level of is not considered positive– but does require removal from duty for a period of at least 8 hours for FTA and 24 hours for FMCSA Positive result is 0.04 and above

31 Alcohol Testing Continued
Following an accident that meets the criteria to conduct testing; all employees subject to testing are prohibited from consuming alcohol for a period of eight hours following the accident or until post accident tests are completed Failure to locate a breath alcohol technician or saliva test technician are not legitimate excuses for failure to conduct testing following an accident that meets the criteria to test

32 Laboratory Process

33 Prohibited Drugs Marijuana Cocaine Amphetamines Opiates PCP
These are the only drugs permitted to be tested for under DOT authority

34 Lab Analysis All labs used for the purpose of DOT urine drug analysis must be certified by the Dept. of Health and Human Services A list of currently certified labs is published the first week of each month in the federal register Labs are heavily monitored by DOT and DHHS Effective August 25, 2008; labs are required to conduct specimen validity testing

35 Specimen Validity Testing
SVT is in addition to immunoassay and GC/MS Purpose: to screen for adulterants and substitutions used to interfere with specimen analysis Huge market for products that are designed to “beat drug tests” Even prosthetic devices are being sold!

36 Video News story explores the use of products designed to “beat” a drug test WZZM ABC local affiliate in Grand Rapids Michigan 3:38 in length This and other videos on this topic can be viewed on You-Tube

37 Thwarting the System  Results of about 1,130,000 for beat a drug test. (0.16 seconds)

38 Let’s take a short break

39 Medical Review Officer
MRO

40 MRO Process Medical Review Officer is the gatekeeper of the DOT drug testing program MRO is the only individual that can produce a drug test result for the employer MRO protects employee’s rights by offering an opportunity for employee to present legitimate explanations for lab results that are non-negative

41 MRO Safety Concerns Medical Miranda
Interview process is confidential except when employee reveals information to MRO that could jeopardize public safety MRO has a responsibility to report to employer Employer receives a Negative result, with an attached medication safety concern Employee is told that within five days, prescribing physician must contact MRO to determine alternate medication- employer must have policy in place in order to “stand down” an employee in this circumstance

42 8 MRO Results Employers Can Receive
Negative Negative- Dilute Negative- Dilute with creatinine in the 2-5 range Invalid Cancelled Positive Positive- Dilute Refusal to Test- Adulterated or Substituted

43 Employer Actions following Each Result
Negative- applicant/employee may begin, resume or continue safety sensitive functions Negative Dilute- employer policy must indicate if negative dilute results will require retesting. (Note: employer must be consistent in enforcement and not use direct observation procedures) § 40.197  Second result is final result Negative Dilute with creatinine in 2-5 range- employee or applicant must undergo a second collection under direct observation** MRO will report quantitative data in this instance and instructions to recollect under direct observation § 40.197 Cancelled or Invalid- actions will differ depending on circumstances; follow MRO instructions

44 Employer Actions Cont. Positive- applicant/employee must be prohibited from performing safety sensitive duties upon receipt of positive result, referral to SAP required Positive-Dilute- same as above Refusal to Test (either adulterated or substituted)- same as above Applicants and current employees who test positive or refuse a DOT required test MUST receive a referral to a qualified Substance Abuse Professional (SAP) regardless of second chance or zero tolerance policy.

45 Substance Abuse Professional
SAP

46 Substance Abuse Professional (SAP)
Regardless of whether employer policy is Zero Tolerance or Second Chance– all violating applicants and employees must be referred to a SAP that meets the qualifications per Part 40 Return to duty process includes two face-to-face evaluations with SAP and employee SAP must provide initial evaluation letter to employer

47 SAP continued SAP determines form of treatment needed
SAP provides return to duty release letter upon employee’s completion of program SAP prescribes the number and frequency of follow up testing. Minimum is 6 tests within 12 months. Employer determines testing dates in accordance with SAP (employer must never decrease or increase the follow up testing schedule per SAP) Employee is subject to all other DOT testing during follow up program

48 Rx and OTC Medications

49 Prescription and OTC Meds
Some commonly prescribed (and often abused) medications such as Vicodin, Xanax Valium and sleep aids are not detected as part of the DOT urine drug test Employers are strongly encouraged to develop policies and procedures that will obligate employees to report the use of prescribed medication and OTC medication that carries a warning label

50 Rx and OTC Awareness Employers should develop training materials and training sessions on the topic of Rx and OTC Safety Concerns Effects of medication on motor functions Possible adverse interaction of medicines Importance of communicating job functions to doctors and pharmacists Importance of reporting to supervisor when illness or medication causes impairment Employers must develop protocol for employees who report impairment

51 Resources for Training Materials
Substance Abuse and Mental Health Services Administration FTA Rx and OTC Medications Toolkit National Institute on Drug Abuse

52 Administrative Duties

53 Records Management All records pertaining to drug and alcohol testing program management must be kept confidential Locked file cabinet in locked office with access granted only to those involved in the administration of the program HR/Personnel records must be kept in a separate location Best Practice is to keep all records for a period of no less than 5 years

54 Records Management Cont.
No news is NOT good news. You must have a verified MRO result on file to consider a negative result Best Practice is to file by year; separate by test type Best Practice Method of filing results Testing Notification Form Employer copy of CCF Test Result (on top)

55 Collection Site Monitoring
Not a regulatory requirement, however collection site compliance = your compliance Inspect site for security risks (ex: water sources not secured, contaminants available in stall, collector not requiring pockets be emptied, bluing agent not present in toilet bowl and tank) Ask collector to conduct a mock collection Ask collector how they would handle “problem collections” such as cold specimens or shy bladder scenarios Develop a good rapport with collection sites- keep lines of communication open

56 Resources for Program Management
ODAPC: Office of Drug and Alcohol and Policy Compliance Employer handbook Employee handbook Links to all DOT modes, regulations Link to Part 40 List of certified labs Sign up for auto s

57 Let’s take a break!

58 Supervisor Refresher Training
Reasonable Suspicion Determinations

59 Training Requirements for both FMCSA and FTA
Each employer shall ensure that all persons designated to supervise drivers receive at least 60 minutes of training on alcohol misuse and receive at least an additional 60 minutes of training on controlled substances use. The training will be used by the supervisors to determine whether reasonable suspicion exists to require a driver to undergo testing under The training shall include the physical, behavioral, speech, and performance indicators of probable alcohol misuse and use of controlled substances. Recurrent training for supervisory personnel is not required.

60 Video Clean Sober and Safe
This portion of the video covers the five DOT prohibited substances and alcohol Discusses the effects of drugs and alcohol on the mind and body

61 Determination and Documentation Process
Determinations must not be based on hearsay, gossip or rumor Determinations must be based on specific, contemporaneous, articulable observations made by at least one trained supervisor Documentation of observations is critical- (and required for FMCSA) See example of Documentation Form

62 Interview Process Ensure that all measures are taken to respect employee’s privacy and dignity Conduct interview behind closed doors If feasible, ask another trained supervisor to assist with the determination process HOWEVER, if second supervisor does not make same determination– continue to process under your own authority

63 Interview Process Cont.
Explain to employee the behaviors, speech or performance indicators that you have observed Allow employee time to respond Do not let employee’s “excuses” cloud your judgment Explain to employee that the reasonable suspicion testing is designed to “rule out” possible prohibited drug use or alcohol misuse as an explanation for the observations made Explain that as a supervisor, you have an obligation to act when you have observed behavior, speech or performance indicators that could jeopardize the safety of employees as well as the public

64 Interview Process Cont.
Do not try to counsel or advise employee. Do not try to analyze the drug or drugs that the employee may be taking At all times behave in a professional and calm manner Do not hesitate to contact law enforcement should an employee’s behavior turn combative or violent Transport or arrange for transport of employee to testing site and then home

65 Please break into groups of 6-8
Group Exercise Please break into groups of 6-8

66 Scenarios Read each of the scenarios
For each scenario, list as many “errors” in the scenario as possible List the ways in which you would handle the same situations differently Designate two members of your group to role-play one of the scenarios after our break

67 Let’s take a short break
Role-play exercise when we return

68 Thank You Thank you for your attendance today
Please visit the FDOT/CUTR Substance Abuse Management (SAM) website to download this presentation


Download ppt "Good Morning~ Welcome! Today’s presentation is sponsored by the Florida Department of Transportation Our host agency is the Central Florida Regional Planning."

Similar presentations


Ads by Google